These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A comparative in-vitro evaluation of resistance selection after exposure to teicoplanin, vancomycin, linezolid and quinupristin-dalfopristin in Staphylococcus aureus and Enterococcus spp. Drago L; Nicola L; De Vecchi E Clin Microbiol Infect; 2008 Jun; 14(6):608-11. PubMed ID: 18397336 [TBL] [Abstract][Full Text] [Related]
3. Importance of the structure of vancomycin binding pocket in designing compounds active against vancomycin-resistant enterococci (VRE). Jia Y; Bois-Choussy M; Malabarba A; Brunati C; Zhu J J Antibiot (Tokyo); 2006 Sep; 59(9):543-52. PubMed ID: 17136887 [TBL] [Abstract][Full Text] [Related]
5. Bactericidal activity of daptomycin, vancomycin, teicoplanin and linezolid against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium using human peak free serum drug concentrations. Brauers J; Kresken M; Menke A; Orland A; Weiher H; Morrissey I Int J Antimicrob Agents; 2007 Mar; 29(3):322-5. PubMed ID: 17204403 [TBL] [Abstract][Full Text] [Related]
7. Synthesis of rigidly-linked vancomycin dimers and their in vivo efficacy against resistant bacteria. Lu J; Yoshida O; Hayashi S; Arimoto H Chem Commun (Camb); 2007 Jan; (3):251-3. PubMed ID: 17299629 [TBL] [Abstract][Full Text] [Related]
8. N'-(alpha-aminoacyl)- and N'-alpha-(N-alkylamino)acyl derivatives of vancomycin and eremomycin. II. Antibacterial activity of N'-(alpha-aminoacyl)- and N'-alpha-(N-alkylamino)acyl derivatives of vancomycin and eremomycin. Plattner JJ; Chu D; Mirchink EP; Isakova EB; Preobrazhenskaya MN; Olsufyeva EN; Miroshnikova OV; Printsevskaya SS J Antibiot (Tokyo); 2007 Apr; 60(4):245-50. PubMed ID: 17456974 [TBL] [Abstract][Full Text] [Related]
9. Solid-phase synthesis and antibacterial evaluations of N-demethylvancomycin derivatives. Yao NH; Liu G; He WY; Niu C; Carlson JR; Lam KS Bioorg Med Chem Lett; 2005 May; 15(9):2325-9. PubMed ID: 15837318 [TBL] [Abstract][Full Text] [Related]
11. [A 6-year study of glycopeptides-resistant enterococci in 3 intensive care units of the University Hospital of Montpellier]. Godreuil S; Marchandin H; Boulier A; Boumzebra A; Campos J; Jean-Pierre H Pathol Biol (Paris); 2007 Nov; 55(8-9):418-23. PubMed ID: 17905540 [TBL] [Abstract][Full Text] [Related]
12. Incorporation of glucose analogs by GtfE and GtfD from the vancomycin biosynthetic pathway to generate variant glycopeptides. Losey HC; Jiang J; Biggins JB; Oberthür M; Ye XY; Dong SD; Kahne D; Thorson JS; Walsh CT Chem Biol; 2002 Dec; 9(12):1305-14. PubMed ID: 12498883 [TBL] [Abstract][Full Text] [Related]
13. Model for antibiotic optimization via neoglycosylation: synthesis of liponeoglycopeptides active against VRE. Griffith BR; Krepel C; Fu X; Blanchard S; Ahmed A; Edmiston CE; Thorson JS J Am Chem Soc; 2007 Jul; 129(26):8150-5. PubMed ID: 17564440 [TBL] [Abstract][Full Text] [Related]
15. Methicillin-resistant Staphylococcus aureus has a beta-lactamase enzyme that can be plasmid-located: ejectable when under attack by adjunct antibiotics. Wiseman A Med Hypotheses; 2006; 66(1):204-5. PubMed ID: 16198501 [No Abstract] [Full Text] [Related]
16. A new series of glycopeptide antibiotics incorporating a squaric acid moiety. Synthesis, structural and antibacterial studies. Sztaricskai F; Batta G; Herczegh P; Balázs A; Jeko J; Roth E; Szabó PT; Kardos S; Rozgonyi F; Boda Z J Antibiot (Tokyo); 2006 Sep; 59(9):564-82. PubMed ID: 17136889 [TBL] [Abstract][Full Text] [Related]
17. Vancomycin resistance: are there better glycopeptides coming? Linden PK Expert Rev Anti Infect Ther; 2008 Dec; 6(6):917-28. PubMed ID: 19053904 [TBL] [Abstract][Full Text] [Related]
18. Solid-phase synthesis and antibacterial activity of hydroxycinnamic acid amides and analogues against methicillin-resistant Staphylococcus aureus and vancomycin-resistant S. aureus. Yingyongnarongkul BE; Apiratikul N; Aroonrerk N; Suksamrarn A Bioorg Med Chem Lett; 2006 Nov; 16(22):5870-3. PubMed ID: 16942872 [TBL] [Abstract][Full Text] [Related]
19. [Factors of virulence and mechanisms of resistance to aminoglycosides in clinical isolates of Enterococcus faecalis and Enterococcus faecium with high-level gentamicin resistance]. Filipová M; Bujdáková H Epidemiol Mikrobiol Imunol; 2005 Apr; 54(2):65-74. PubMed ID: 16050545 [TBL] [Abstract][Full Text] [Related]
20. Exploiting the reversibility of natural product glycosyltransferase-catalyzed reactions. Zhang C; Griffith BR; Fu Q; Albermann C; Fu X; Lee IK; Li L; Thorson JS Science; 2006 Sep; 313(5791):1291-4. PubMed ID: 16946071 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]